serw-MX  [xml]  
 


    
 DeCS Categories

D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.954 Therapeutic Uses .
D27.505.954.248 Antineoplastic Agents .
D27.505.954.248.169 Antineoplastic Agents, Hormonal .
E02 Therapeutics .
E02.183 Clinical Protocols .
E02.183.750 Antineoplastic Protocols .
E02.183.750.500 Antineoplastic Combined Chemotherapy Protocols .
E02.319 Drug Therapy .
E02.319.077 Antineoplastic Protocols .
E02.319.077.500 Antineoplastic Combined Chemotherapy Protocols .
E02.319.310 Drug Therapy, Combination .
E02.319.310.037 Antineoplastic Combined Chemotherapy Protocols .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Antineoplastic Combined Chemotherapy Protocols .
Antineoplastic Combined Chemotherapy Regimens .
Combined Antineoplastic Agents .
Agent, Combined Antineoplastic .
Agents, Combined Antineoplastic .
Anticancer Drug Combination .
Antineoplastic Agent, Combined .
Antineoplastic Chemotherapy Protocol .
Antineoplastic Drug Combination .
Cancer Chemotherapy Protocol .
Chemotherapy Protocol, Antineoplastic .
Chemotherapy Protocol, Cancer .
Chemotherapy Protocols, Cancer .
Combinations, Antineoplastic Drug .
Combined Antineoplastic Agent .
Drug Combination, Anticancer .
Drug Combination, Antineoplastic .
Drug Combinations, Anticancer .
Protocol, Antineoplastic Chemotherapy .
Protocol, Cancer Chemotherapy .
Protocols, Antineoplastic Chemotherapy .
Protocols, Cancer Chemotherapy .
Anticancer Drug Combinations .
Antineoplastic Agents, Combined .
Antineoplastic Chemotherapy Protocols .
Antineoplastic Drug Combinations .
Cancer Chemotherapy Protocols .
Chemotherapy Protocols, Antineoplastic .
Drug Combinations, Antineoplastic .
The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. .
1.00
446123549
 
Antineoplastic Agents .
Anticancer Agents .
Antineoplastic Drugs .
Antineoplastics .
Antitumor Agents .
Antitumor Drugs .
Cancer Chemotherapy Agents .
Cancer Chemotherapy Drugs .
Chemotherapeutic Anticancer Agents .
Chemotherapeutic Anticancer Drug .
Agents, Anticancer .
Agents, Antineoplastic .
Agents, Antitumor .
Agents, Cancer Chemotherapy .
Agents, Chemotherapeutic Anticancer .
Chemotherapy Agents, Cancer .
Chemotherapy Drugs, Cancer .
Drug, Chemotherapeutic Anticancer .
Drugs, Antineoplastic .
Drugs, Antitumor .
Drugs, Cancer Chemotherapy .
Antineoplastic and Immunosuppressive Agents .
Antineoplastics, Immunosuppressives .
Substances that inhibit or prevent the proliferation of NEOPLASMS. .
0.83
1032234327
 
Antineoplastic Agents, Hormonal .
Antineoplastic Drugs, Hormonal .
Antineoplastic Hormonal Agents .
Antineoplastic Hormonal Drugs .
Antineoplastics, Hormonal .
Hormonal Agents, Antineoplastic .
Hormonal Antineoplastic Drugs .
Hormonal Antineoplastics .
Agents, Antineoplastic Hormonal .
Drugs, Antineoplastic Hormonal .
Hormonal Drugs, Antineoplastic .
Hormonal Antineoplastic Agents .
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) .
0.67
8514736